Monthly Prescribing Reference2h
Ropeginterferon Alfa-2b Effective in Essential Thrombocythemia Trial
The Company is also studying P1101 in the single-arm phase 2B EXCEED-ET trial (ClinicalTrials.gov Identifier: NCT05482971) to evaluate the efficacy, safety, and tolerability of P1101 in adult patients ...
Monthly Prescribing Reference4h
SubQ Copper Histidinate Formulation Gets Priority Review for Menkes Disease
The NDA is supported by data from the open-label, single-center phase 1/2 90-CH-0149 trial and the open-label, single-arm phase 3 09-CH-0059 study.
Monthly Prescribing Reference7h
Study Compares Single-Inhaler Triple Therapies for Treatment of COPD
Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...
Monthly Prescribing Reference8h
Early Anti-TNFα Therapy Cuts Perianal Fistula Complications in Pediatric Crohn Disease
Odds of complications significantly reduced with early anti-TNFα therapy, especially in those with perianal lesions ...
Monthly Prescribing Reference8h
Human A(H5N1) Cases Generally Have Mild Illness, With Short Duration
(HealthDay News)-— The A (H5N1) virus generally causes mild illness of short duration, mainly among US adults exposed to infected animals, according to a study published online Dec. 31 in the New ...